The manufacturing process for cell and gene therapy products is dependent on the product itself, the disease and patient logistics. Cellular therapy manufacturing process is determined on whether the therapy is autologous, allogeneic and/or gene modified. Gene therapy development is dependent on the vector used and where the genetic modification takes place. It is critical for those working in CGT manufacturing to understand the essentials such as cryogenics, cell handling, aseptic working and GMP requirements. Our CGT manufacturing training provides you with the skill and confidence to develop and manufacture successful treatments. Courses on cell therapy manufacturing process examine both autologous and allogeneic therapies. We also deliver courses on gene therapy development and viral vectors.
CGT manufacturing training courses include: Aseptic working | GMP | cryogenics | cell handling | cell therapy manufacturing process | autologous/allogeneic cell therapy manufacturing | gene therapy manufacturing | ex vivo gene therapy | in vivo gene therapy
We have partnered with a range of organisations to help us deliver the best training for our customers. Through our memberships and partners, we remain up-to-date with the latest news, trends and innovations industry across the life sciences industry. To view all of our partnerships. Specifically in cell & gene therapies we have a proud media partnership with Gene Therapy Net.
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.